These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6173658)

  • 21. Heterogeneous nuclear RNA promotes synthesis of (2',5')oligoadenylate and is cleaved by the (2',5')oligoadenylate-activated endoribonuclease.
    Nilsen TW; Maroney PA; Robertson HD; Baglioni C
    Mol Cell Biol; 1982 Feb; 2(2):154-60. PubMed ID: 6180300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA.
    Farrell PJ; Sen GC; Dubois MF; Ratner L; Slattery E; Lengyel P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5893-7. PubMed ID: 282611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymic synthesis, purification, and fractionation of (2'-5')-oligoadenylic acid.
    Hovanessian AG; Brown RE; Martin EM; Roberts WK; Knight M; Kerr IM
    Methods Enzymol; 1981; 79(Pt B):184-93. PubMed ID: 6173664
    [No Abstract]   [Full Text] [Related]  

  • 24. Enzymic synthesis of (2'-5')ppp3'dA(p3'dA)n, the cordycepin analog of (2'-5')-oligoadenylic acid.
    Suhadolnik RJ; Doetsch P; Wu JM; Sawada Y; Mosca JD; Reichenbach NL
    Methods Enzymol; 1981; 79(Pt B):257-65. PubMed ID: 6173670
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-free protein synthesis and interferon action: protein kinase(s) and an oligonucleotide effector, pppA2'p5'A2'p5'A.
    Kerr IM; Williams BR; Hovanessian AG; Brown RE; Martin EM; Gilbert CS; Birdsall NJ
    Haematol Blood Transfus; 1979; 23():291-4. PubMed ID: 94574
    [No Abstract]   [Full Text] [Related]  

  • 26. [Induction of enzymes by interferon].
    Vilcek S; Sangret M; Vrtiak OJ
    Arch Exp Veterinarmed; 1984 Mar; 38(2):169-77. PubMed ID: 6204619
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of interferon actions using partially resistant cell variants.
    Sen G; Belkowski L; Kusari J
    Prog Clin Biol Res; 1985; 202():175-82. PubMed ID: 2421300
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase.
    Zilberstein A; Kimchi A; Schmidt A; Revel M
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4734-8. PubMed ID: 283387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of interferon-mediated inhibition of protein synthesis.
    Samuel CE; Kingsman SM; Melamed RW; Farris DA; Smith MD; Miyamoto NG; Lasky SR; Knutson GS
    Ann N Y Acad Sci; 1980; 350():473-85. PubMed ID: 6165298
    [No Abstract]   [Full Text] [Related]  

  • 30. The action of interferon at the molecular level.
    Baglioni C; Nilsen TW
    Am Sci; 1981; 69(4):392-9. PubMed ID: 6169297
    [No Abstract]   [Full Text] [Related]  

  • 31. The 2-5A (pppA2'p5'A2'p5'A) and protein kinase systems in interferon-treated and control cells.
    Kerr IM; Wreschner DH; Silverman RH; Cayley PJ; Knight M
    Adv Cyclic Nucleotide Res; 1981; 14():469-78. PubMed ID: 6169260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Messenger RNA methylation, translation and degradation in extracts of interferon-treated cells.
    Sen GC; Desrosiers R; Ratner L; Shaila S; Brown GE; Lebleu B; Slattery E; Kawakita M; Cabrer B; Taira H; Lengyel P
    Tex Rep Biol Med; 1977; 35():221-9. PubMed ID: 358450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [tRNA as an activator of protein kinase induced by interferon].
    Verkhatskaia AA; Ribkinska TA; Sidorik LL; Matsuka GKh
    Dokl Akad Nauk SSSR; 1985; 280(1):233-5. PubMed ID: 2579783
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular mechanisms of interferon action: interferon-mediated phosphorylation of ribosome-associated protein P1 and protein synthesis initiation factor eIF-2.
    Samuel CE
    Tex Rep Biol Med; 1981-1982; 41():463-70. PubMed ID: 6189210
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of interferon action. Studies on the mechanism of interferon-mediated inhibition of reovirus messenger RNA translation in cell-free protein synthesis systems from mouse ascites tumor cells.
    Samuel CE
    Virology; 1976 Nov; 75(1):166-76. PubMed ID: 982845
    [No Abstract]   [Full Text] [Related]  

  • 36. Structural requirements of polynucleotides for the activation of (2' - 5')An polymerase and protein kinase.
    Baglioni C; Minks MA; De Clercq E
    Nucleic Acids Res; 1981 Oct; 9(19):4939-50. PubMed ID: 6273790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular basis of the antiviral activity of interferons: introductory remarks.
    Joklik WK
    Ann N Y Acad Sci; 1980; 350():432-40. PubMed ID: 6165294
    [No Abstract]   [Full Text] [Related]  

  • 38. The 2-5A system: a personal view.
    Kerr IM
    J Interferon Res; 1987 Oct; 7(5):505-10. PubMed ID: 2445848
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular mechanisms of interferon action.
    Ball LA
    Med Pediatr Oncol; 1981; 9(1):83-8. PubMed ID: 6162086
    [No Abstract]   [Full Text] [Related]  

  • 40. Impairment of intracellular antiviral defense with age: age-dependent changes in expression of interferon-induced and double-stranded RNA-activated 2-5A synthetase in rat.
    Kuusksalu A; Truve E; Aaspollu A; Kelve M; Scheffer U; Müller WE; Schröder HC
    Mech Ageing Dev; 1995 Mar; 78(2):103-15. PubMed ID: 7541098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.